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ABSTRACT 
 
BACKGROUND: 
 Diagnosis of the active phase of periodontal disease and 
identifying the patients at risk for active disease is being a challenge 
for clinical investigators.  The traditional method of diagnosing 
periodontitis  one includes assessment of clinical parameters and 
radiographic aids to evaluate the periodontal tissue destruction. Saliva 
has the potential  to be used as the diagnostic fluid for oral  disease.  Its 
easy method of collection through non -invasive methods. Evaluation of 
ALP by simplified method of spectrometry and i ts cheaper analysis 
cost  makes the biomarker ALP as a resil ient  and reliable one for the 
diagnosis of periodontal  disease activity  
 
AIM: 
The aim of this study is to compare the quantitative levels  of 
Alkaline phosphatase in saliva and serum before and after scaling and 
root planing in patients with chronic generalised periodontit is.  
 
MATERIALS AND METHODS: 
 A total  number of 50 subjects (40 with chronic generalised 
periodontitis and 10 periodontally healthy volunteers) of 30 to 50 years 
were included in the study. After getting the informed consent signed, 
all the individuals participated in the study were su bjected to 
measurement of clinical parameters such as OHI-S, Gingival index, 
probing depth and CAL and then saliva and blood sample collection 
was done and analysed for ALP levels by spectrometry.  The clinical  
parameters, saliva and serum ALP were re-evaluated after 30 days 
following phase 1 periodontal therapy. The results were statistically 
analysed using paired t test  and One -way ANOVA. 
 
RESULTS: 
The saliva and serum ALP levels were significantly increased in 
patients with chronic generalised periodontitis with increase in clinical  
parameters such as OHI-S, Gingival index, probing depth and CAL 
when compared with periodontally healthy individuals. The saliva and 
serum ALP levels were significantly decreased following phase 1 
periodontal therapy along with improvement in clinical parameters thus 
exhibiting a posit ive correlation between clinical  parameters with both 
saliva and serum ALP levels. P values from the statist ical tests 
presented were found to be statistically highly significant at P-value 
.000** 
 
CONCLUSION: 
 With the limitations of the present study it could be concluded 
that  ALP levels in saliva can be used for the diagnosis of active phase 
of periodontal disease and also for evaluation of the treatment 
outcomes following periodontal phase 1 therapy.  
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INTRODUCTION 
 
Chronic periodontitis has been defined as “an infectious disease 
resulting in inflammation within the supporting tissues of the teeth, 
progressive attachment loss, and bone loss. 
 
Although periodontitis is an infectious disease of gingival tissue 
origin, changes that occur in the bone are crucial as the alveolar bone 
destruction is responsible for tooth loss. The most common cause of 
alveolar bone destruction in periodontitis  is the extension of 
inflammation from the marginal gingiva to the underlying periodontal 
tissues.
1  
 
Biochemical markers can detect inflammatory changes in short 
period of time whereas longer period is required to detect measurable 
changes in bone density using radiographs.  
 
Salivary constituents  for diagnosing periodontal disease includes 
enzymes and immunoglobulins, hormones of host origin, bacteria and 
bacterial products, ions, and volatile compounds.
2  
 
Intracellular enzymes are released  progressively into the gingival 
crevicular fluid (GCF) and saliva  from the damaged cells of 
periodontal tissues. Several enzymes that are evaluated for the early 
diagnosis of periodontal disease includeslactate dehydrogenase (LDH), 
aspartate and alanine aminotransferase (AST, ALT), creatine kinase 
(CK), alkaline and acid phosphatase (ALP, ACP), and gamma 
glutamiltransferase (GGT).  
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ALP is a hydrolase enzyme responsible for removing phosphate 
groups from many types of molecules and is a marker of bone 
metabolism. It  is a membrane-bound glycoprotein produced by various 
number of cells,  such as polymorphonuclear leukocytes, macrophages,  
fibroblasts and osteoblasts,  within the area of the periodontium and 
gingival crevice.
3  
 
Studies demonstrated that the elevated serum ALP level is 
associated with patients with chronic kidney disease .
4
 Studies have 
also shown increased ALP activity in Pos t-menopausal women with 
periodontitis compared with non-periodontitis individuals.
5  
 
ALP is very important enzyme in the periodontium, as it  is part 
of normal turnover of periodontal ligament, root cementum and 
maintenance, and bone homeostasis.  
 
Various studies have assessed the levels of salivary ALP with 
respect to gingivitis, chronic periodontitis and correlation with clinical 
parameters. But there is lagging evidence regarding the comparative 
effects of ALP in serum and saliva following periodontal tr eatment.  
 
Totan et al.
 6
 investigated the influence of periodontal disease 
on ALP, aspartate aminotransferase (AST), aminopeptidase, and 
glucuronidase. Salivary samples were evaluated in patients with 
periodontal disease showed that periodontal destruction along with the 
probing depth, gingival bleeding index, and suppuration were related to 
elevated ALP levels in saliva. These results were also support ed by the 
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findings in the study conducted by Todorovic et al. 
7  
that there was an 
increased activity of salivary ALP in patients with periodontal disease 
in relation to periodontally healthy group. The study group further 
showed a positive correlation between the salivary enzyme activity and 
gingival index values  thereby indicating that ALP levels of an 
individual may best serve as a marker in periodontal treatment planing 
and monitoring.
8 ,9
 
 
ALP levels in saliva can be detected same as serum ALP 
estimation by using UV spectrometry and its analysis is cost -effective. 
So far,  ALP has not been supported by research findings as a predictive 
indicator for future periodontal t issue breakdown. The purpose of this 
study is to compare the Serum and Salivary ALP leve ls in chronic 
periodontitis patients before and after periodontal phase 1 therapy 
which serves to hold to the hypothesis that saliva can be used as an 
alternative to serum for evaluating ALP as a biomarker in periodontal 
disease progression.  
 
Aim and Objectives 
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AIM AND OBJECTIVES 
 
The aim of this study is to compare the quantitative levels of 
ALP in serum and saliva before and after scaling and root planing in 
patients with chronic generalised periodontitis.  
 
For this purpose, the following objectives were undertaken:  
 
1. To evaluate and compare the saliva and serum ALP levels in chronic 
generalized periodontitis patients with that of periodontally healthy 
individuals.  
 
2. To compare and correlate the  clinical parameters such as OHI-S, 
gingival index, probing depth and CAL with biomarker levels of 
serum and salivary ALP in patients with chronic generalized 
periodontitis at baseline and following phase 1 periodontal therapy.  
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GENERAL REVIEW 
 
ALP is a membrane-bound glycoprotein produced by numerous 
cells,  such as osteoblasts,  macrophages, polymorphonuclear leukocytes 
and ﬁbroblasts within the area of the periodontium and gingival 
crevice.  ALP activity in serum has been extensively studied for the 
past few years, and it was suggested that ALP allows bone 
mineralization by releasing an organic phosphate, contributing to the 
deposition of calcium-phosphate complexes into the osteoid matrix. 
ALP might also promote mineralization by inorganic pyrophosphate  
hydrolyzation, which acts as a potent inhibitor of hydroxyapatite 
crystal mineralization and dissolution, within the extracellular 
calcifying matrix vesicles .
1 0  
 
In general,  accelerated bone loss is related to an increased bone 
turnover rate, accompanied by increased levels of serum and urine 
biochemical markers of bone turnover, such as collagen cross -links, 
alkaline phosphatase (ALP), and osteocalcin.  
 
ALP activity is mostly present in all  the organs of the body and 
is especially associated with membranes and cell  surfaces located in 
mucosa of small intestine and proximal convoluted tubules of the 
kidney, in bone (osteoblasts),  liver and placenta. Although t he 
metabolic function of the enzyme is not understood, it  appears that 
ALP is associated with lipid transport in the intestine and with the 
calcification process in bone.
11  
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DIAGNOSTIC SIGNIFICANCE OF ALP 
 Higher levels of ALP is having more value for diag nostic 
significance in the evaluation of hepatobiliary and bone disorders. In 
hepatobiliary disorders, elevations are seen more predominantly in 
obstructive conditions than in hepatocellular disorders. In bone 
disorders, elevations are seen when there is i nvolvement of the 
osteoblasts.  
 
 In biliary tract obstruction, ALP levels range from 3 to 10 times 
due to increased synthesis of the enzyme induced by cholestasis.  In 
contrast,  3 fold increase is seen in hepatocellular disorders like 
hepatitis and cirrhosis. 
  
 The bone isoenzyme increases due to potent  osteoblastic activity 
and also the levels are normally elevated in children during periods of 
growth and in adults older than age 50 years, where an elevated ALP 
level may be difficult  to interpret.  
  
 Individuals who have blood group B or O shows presence of 
intestinal ALP isoenzyme in serum. Furthermore, in these individuals,  
increases in intestinal ALP occur after consumption of a fatty meal. 
Increased levels are also found in patients undergoing chro nic 
hemodialysis.  
  
 In normal pregnancy, increased ALP activity, averaging one and 
one-half times can be detected between 16-20 weeks of pregnancy. 
ALP activity increases and persists until  the onset of Labor and then 
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returns to normal within 3 days to 6 days. Elevations also may be seen 
in complications of pregnancy such as hypertension, preeclampsia and 
eclampsia, as well as in threatened abortion.  
  
 Elevated ALP levels may be seen in a variety of bone disorders. 
Conceivably the highest elevations of ALP activity occurs primarily in 
Paget’s disease (osteitisdeformans). Other bone disorders including 
rickets,osteomalacia, hyperparathyroidism, and osteogenic sarcoma 
were also documented with increased ALP levels. In addition, 
increased levels are seen in the case of healing bone fractures and 
during periods of physiologic bone growth. 
13  
  
 ALP levels are significantly decreased in the inherited condition 
of hypophosphatasia. Subnormal activity is due to the absence of the 
bone isoenzyme and results in inadequate bone calcification.  
 
ALP levels have often been evaluated in gingival crevicular fluid 
(GCF) to validate the relationship between periodontal conditions and 
disease activity.
1 2 ,13  
 
Plagnat et al.
14
 studied ALP in GCF from implants with and 
without peri-implantitis and suggested that ALP could be a promising 
marker of bone loss around dental implants. Gibert et al.
 15
 studied the 
activity of ALP in serum from patients with chronic periodontitis and 
showed a relationship between loss of attachment in p eriodontal 
disease and ALP activity in serum. Binder et al.
 13
 performed a 
longitudinal study of eight patients and demonstrated a positive 
correlation between GCF ALP concentration and attachment loss.  
Review of Literature 
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REVIEW OF LITERATURE 
 
The diagnosis of active phases of periodontal disease and the 
identification of patients at the risk for active disease are challenges 
for clinical investigators and practitioners alike. Researchers are 
confronted with the need for innovative diagnostic te sts that focus on 
the early recognition of the microbial challenge to the host.  Optimal 
innovative approaches would correctly determine the presence of 
current disease activity, for future periodontal breakdown and to 
evaluate the response to periodontal i nterventions. Hence, a new 
paradigm for periodontal diagnosis would ultimately improve the 
clinical management of patients with periodontal disease. 
1 6  
 
SALIVA IN THE FIELD OF DIAGNOSIS: 
17  
Analysis of blood and its compounds has been used for several 
decades for lab diagnostic procedures. However, other biological fluids 
are also utilized frequently for the diagnosis of disease, for example, 
urine, cerebrospinal fluid and thus saliva which could offer some 
distinct advantages in certain situations.  
 
Electrolytes enter the saliva via osmotic gradients and are 
regulated by rate of secretion, nature of stimulus and level of 
mineralocorticoids in the circulation. Because serum components of 
saliva are derived primarily from local vasculature that originates fro m 
the carotid arteries, saliva has a prodigious fluid source that provides 
many, if not most, of the same molecules found in the systemic 
Review of Literature 
 
9 
 
circulation. This makes saliva as a potentially valuable fluid for the 
diagnosis of various systemic diseases.  
  
 There are 3 major salivary glands (Parotid, submandibular and 
sublingual) that secrete saliva into the oral cavity. Saliva from these 
glands provides different mixtures of serous and mucinous derived 
fluid and is primarily useful for the detection of gland spe cific 
pathology. 
 
Whole saliva, by contrast is composed by a mixture of oral fluids 
from the major salivary and minor salivary glands and also contains 
constituents of non salivary origin, including Gingival Crevicular Fluid 
(GCF), serum transudate from the mucosa and sites of inflammation, 
epithelial and immune cells,  food debris and many microbes. Whole 
saliva is most frequently studied because, its collection is easy, non -
invasive and rapid to obtain without the need for specialised 
equipment.  
 
Unstimulated saliva is commonly collected by the draining 
method, where the subject’s head is ti lted forward so that saliva moves 
towards the anterior region of the mouth and the pooled saliva is  
drooled into a wide sterile container. To date, unstimulated whole 
saliva has been used in the majority of diagnosis studies.  
 
SALIVARY BIOMARKERS OF PERIODONTAL DISEASE:  
Saliva is appealing for use as a diagnostic fluid for point of care 
analysis for oral related diseases, because it is rapid, easy and non -
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invasive to collect and generally readily abundant. However, few 
studies have longitudinally monitored salivary biomarker profiles in 
patients with respect to periodontal status or determined if salivary 
biomarkers accurately represent periodontal disease status over time, 
its concentration of analytes should diminish in response to periodontal 
therapy.
1 8  
 
 
 
“Robust biomarkers” are defined as those salivary proteins 
which have been shown to discriminate between periodontitis and oral 
health in at least 3 cross-sectional studies and for which there may be 
supporting evidence from longitudinal studies investigating the natural 
course of periodontitis and for the effects of treatment on biomarker 
levels.  
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“Potential biomarkers” are defined using identical criteria to 
robust biomarkers with the exception that there are 2 replicated cross -
sectional studies showing disease discrimination in addition to possible 
supporting evidence from longitudinal studies but for which there may 
be limited contradictory studies. It  is accepted that the entries in the 
robust and potential categories may be interchangeable depending on 
the existence of further studies which remain unpublished for 
commercial reasons.  
 
“Uncertain biomarkers” are proteins for which there are only 
single study showing discrimination of periodontitis or for which there 
are several studies from which the evidence is contradictory.  
 
“Unlikely biomarkers” are those proteins for which there are 3 
or more studies which fail  to provide evidence for an associati on with 
periodontitis in the absence of any evidence to the contrary. 
19  
 
MARKERS OF ALVEOLAR BONE LOSS:  
 Many different biomarkers associated with bone formation, 
resorption and turn over such as Alkaline Phosphatase, Osteocalcin, 
Osteonectin and collagen telopeptidases have been evaluated in the 
GCF and saliva. These mediators are associated with local bone 
metabolism (in periodontitis) as well as with systemic conditions 
(Osteoporosis or Metastatic bone cancers).  
16  
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Badersten A et al. ,  1981 
20  
Investigated healing after non-surgical periodontal therapy in 
patients with periodontal pockets depth of 4 -7mm in 15 patients. 
Patients were treated by  supra and subgingival scaling either with hand 
or ultrasonic instruments. Clinical parameters like plaq ue scores, 
bleeding on probing, probing pocket depths and probing attachment 
levels were evaluated. There was improvement in clinical parameters 
during the initial 4–5 months after start  of therapy and then a lit tle 
change occurred during the rest of the 1 3-month observation period. 
Total of 106 sites demonstrated probing pocket depths ≥ 6 mm. At 13 
months only 13 such sites were observed. The results revealed that the 
conservative treatment of patients with 4 –7 mm deep pockets shown 
better clinical outcomes in the study, provided with the raise of 
question to what extent nonsurgical therapy is feasible also in patients 
with severely advanced lesions.  
 
Isidor F et al. ,  1984 
21  
Evaluated the effect of root planing  as compared to that of 
surgical periodontal treatment in 17 patients with advanced periodontal 
disease. Following initial examination, the teeth were scaled and the 
patients were given instruction in performing proper oral hygiene. The 
hygienic phase for the individual patient was continued until  less than 
20% of the tooth surfaces demonstrated plaque at 2 succeeding 
appointments. After re-assessment of the periodontal status, 1 side in 
both the maxilla and mandible was treated with modified Widman flap 
surgery. In I of the remaining quadrants, in the maxilla or mandible, 
Review of Literature 
 
13 
 
reverse bevel flap surgery was used. Bone contouring was not 
performed in any of the surgical procedures. The last quadrant was 
subjected to meticulous root planing under local anaesthesia . 
Subsequently, the patients were recalled every second week for 
professional tooth cleaning. The periodontal status of each patient was 
assessed at 3
rd
and 6
t h
 months following treatment. Clinical gain of 
attachment was obtained following all 3 modalities,  but root planing 
resulted in slightly more gain of attachment than the 2 surgical  
procedures.  
 
Ramfjord SP et al. ,  1987 
2 2  
Assessed in a clinical trial over 5 years results following 4 
different modalities of periodontal therapy (Pocket elimination or 
reduction surgery, modified Widman flap surgery, Subgingival 
curettage & Scaling and root planing) in 90 on a random basis to each 
of the 4 quadrants of the dentition. Following professional tooth 
cleaning and oral hygiene instructions every 3 months, the poc ket 
depth and attachment levels were scored once a year. 72 patients who 
completed the 5yrs observation were shown that for 1 -3mm probing 
depth, scaling and root planing as well as subgingival curettage led to 
significantly less attachment loss than pocket  elimination and modified 
Widman flap surgery. For 4-6mm pockets, scaling and root planing and 
curettage had better attachment results than pocket elimination surgery 
for 7-12mm pockets, thus concluded that clinical significance of SRP 
&subgingival curettage in treatment of deep periodontal pockets.  
 
Review of Literature 
 
14 
 
Greenstein G 1992 
2 3  
Addressed the advantages and limitations of non -surgical 
periodontal therapies to treat patients with mild to moderate chronic 
periodontitis  by controlled clinical trials and assessed the efficacy of 
following treatment methods like mechanical instrumentation, 
ultrasonic debridement, supragingival and subgingival irrigation along 
with local drug delivery and systemic antibiotic therapy, host 
modulation therapy and concluded that most patients with mild to 
moderate periodontitis can be treated with non -surgical therapy.  
 
Haffajee AD et al.,  1997 
2 4  
Examined the effect of SRP on clinical and microbiological 
parameters in 57 subjects with adult periodontitis.  Clinical and 
microbiological examination was done prior to and 3, 6 and 9 months 
after full-mouth SRP. Clinical parameters included plaque, redness, 
suppuration, BOP, pocket depth and attachment level.  Subgingival 
plaque samples for the presence and levels of 40 subgingival taxa were 
determined using whole genomic DNA probes and checkerboard DNA -
DNA hybridization. Sites with pre -therapy pocket depths of <4 mm 
showed a non-significant increase in pocket depth and attachment 
level. 4–6 mm pockets showed a significant decrease in pocket depth 
and a non-significant gain in attachment post -therapy, while 6 mm 
pockets showed a significant decrease in pocket depth and attachment 
level measurements post -therapy. Clinical improvement post -SRP was 
accompanied by a modest change in the subgingival  microbiota, 
primarily a reduction in  P. gingivalis,  B. forsythus and T. denticola ,  
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suggesting potential targets for therapy and indicating that radical  
alterations in the subgingival  microbiota may not be necessary or 
desirable in many patients.  
 
Cobb CM 2002 
2 5  
Analysed the Egyptian hieroglyphics and medical Papyri to 
evaluate the clinical significance of non -surgical therapy: the 
collective evidence from numerous clinical trials reveals a cons istency 
of clinical response in the treatment of chronic periodontitis by SRP 
remains the “gold standard” thus controlling sub -gingival bacterial 
populations, removal of calculus, root smoothness and also 
improvement in clinical parameters like probing dep th, attachment 
levels, bleeding on probing and gingival inflammation. It  was also 
added that SRP acts as a significant component on a relatively new 
paradigm of complete mouth disinfection in a compressed time frame.  
 
Hue AC et al. ,  1961 
26  
Investigated the acid and alkaline phosphatase activity on both 
whole blood and blood serum in 100 normals and 100 cases of 
periodontal disease and oriented the clinical data with chemical data.  
The results shown that there was no significant difference between the 
acid phosphatase of the normal cases and periodontal cases in either 
whole blood or in plasma. The ALP levels however was higher in the 
blood in periodontal cases suggested the positive correlation of ALP 
with respect to periodontal disease.  
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Ishikawa I et al. ,  1970 
27  
Investigated the correlation between Alkaline Phosphatase (ALP) 
level of activity in Gingival exudate and various clinical parameters, 
collected from incisor and canine region in 21 patients aged 18 -65 
years with extensive gingival inflammation an d periodontitis.  Clinical 
parameters included PMA index, Gingival index, periodontal pocket.  
Radiographic evaluation for bone loss by Marshall -Day and Shourie 
(1949). ALP was measured in 10μl of fluid and 20μl of serum by 
colorimetric technique. The result s of analysis showed positive 
correlation between ALP levels in GCF with that of alveolar bone loss 
in patients with periodontitis along with increased clinical parameters 
concluded stating the prime relevance of ALP levels for diagnosing 
periodontal disease. 
 
Miglani DC et al.,  1974 
28  
Investigated the relationship of ALP to periodontal disease by 
collecting saliva from 45 patients with gingivitis and periodontitis and 
assayed for phosphatase activity by King & Armstrong method. 
Periodontal status of the patients was assessed using Russel’s 
periodontal index and gingival inflammation and periodontal index 
were correlated with ALP activity. Based on the results,  it  was evident 
that with gingivitis, the ALP activity increases. It was then concluded 
that there is a definite rise in ALP activity with an increase in gingival 
score. 
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Chapple IL et al.,  1994 
29  
 Investigated GCF ALP levels in the health and in the presence of 
gingivitis in 30 patients. In gingival health, there was a site specific 
pattern of ALP concentration with higher enzyme concentrations 
around the upper and lower anterior teeth. Furthermore, clinically 
normal sites that had been subjected to different levels of plaque 
control produced significantly different ALP levels, which indicates 
that the biochemical components of GCF may be used to measure the 
sub-clinical inflammatory status. The ratio of GCF to serum ALP 
varied from 6:1 to 11:1 suggesting that the major source of enzymes is 
through local production and analysis of plaque within the s tudy group 
demonstrated very low levels of ALP, indicating that the enzyme is 
likely to be largely derived from the periodontal tissues.  
 
Chapple IL C et al. ,  1999 
3  
 The study aimed to apply a novel enhanced chemiluminescence 
assay in the analysis of GCF ALP levels from 3666 sites in 25 patients 
with untreated adult periodontitis.  Parameters assessed includes 
relative attachment level,  probing pocket depth, bleeding on probing, 
GCF volume (μl), total ALP levels (μIU/30 s sample time) and ALP 
concentration (IU/l). Results shown that there were significant increase 
in total ALP levels and GCF volumes for active sites between baseline 
and 3 months measures; but there was no increase in the ALP 
concentration for control sites or test sites. Thus indicating that  the 
total GCF ALP levels may serve as a predictor of future or current 
disease activity rather than the ALP concentration levels.  
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Gibert P et al. ,  2003 
15  
 The author studied the activity of ALP isoenzyme among the 
other isoforms in the serum of 83 patien ts (59 with periodontal disease - 
chronic periodontitis,  24 as control group) by determining the total  
serum ALP activity and percentage of the different isoforms (bone, 
kidney and intestinal type) by Ektachem analyser and Gel agarose 
electrophoresis respectively. The comparison between the two groups 
resulted a relationship between loss of attachment in periodontal 
disease and a drop in bone ALP activity in serum. Moreover, these 
results suggested a gender based difference as well, with lower activity 
more frequent in women than in men.  
 
DaltabanÖ et al.,  2006 
30  
 The study aimed at determining how estrogen status may 
possibly influence GCF ALP levels in estrogen -deficient (ED) and 
estrogen-sufficient (ES) post -menopausal women at baseline and one 
year after periodontal phase -I treatment in 36 post -menopausal women 
who were divided into two groups; chronic periodontitis and clinically 
healthy patients. The levels of ALP in GCF were measured 
photometrically and other clinical parameters were also measure d at 
baseline and 1year post operatively. Periodontitis  group demonstrated 
significantly increased GCF volumes and GCF ALP levels compared to 
control group. One year after periodontal treatment, the GCF volume, 
total GCF ALP and concentrations decreased significantly in both 
periodontitis group (ES/P; ED/P). Thus suggesting that the presence of 
ALP in GCF is not simply a reflection of the local inflammation state 
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and that a patient’s estrogen status may possibly influence local ALP 
levels in GCF. 
 
Todorovic T et al.,  2006 
7  
 The authors examined the activity of  CK, LDH, AST, ALT, GGT, 
ALP and ACP in saliva from 30 patients with periodontal disease 
before and after phase I periodontal treatment and from 20 healthy 
individuals. Periodontal disease was determined based on clinical 
parameters (Gingival Index, bleeding on probing and probing depth). 
The obtained results shown statistically significant increase of activity 
of CK, LDH, AST, ALT, GGT,ALP and ACP in saliva in patients with 
periodontal disease in relation to control group along with a positive 
correlation between activity of salivary enzymes and value of Gingival 
index and there was significant decrease in activity of all  salivary 
enzymes after treatment. Hence it  was assumed that the activity of 
these enzymes in saliva, as biochemical marker for periodonta l tissue 
damage, may be useful in diagnosis, prognosis and evaluation of 
therapy effects in periodontal disease.  
 
Desai S et al. ,  2008 
3 1  
 The purpose of the study was to evaluate ALP levels in saliva of 
120 patients with chronic periodontitis who were ass igned as 40 in 
each of 3 groups C0, C3 and C4 based on their largest community 
periodontal index of treatment needs CPITN code. Unstimulated saliva 
was collected and analysed with auto analyser using IFCC method in 
order to quantify their ALP concentration s in saliva in each group. It  
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was concluded that the ALP levels in saliva was increased with the 
increase in the CPITN score. Group C0 had the least while group C4 
had the highest ALP levels. Hence, concluded that the salivary ALP 
levels may be useful as a  potential bone turn over marker to establish 
the diagnosis and prognosis of periodontal disease.  
 
Perinetti  G et al.,  2008 
32  
 The study aimed to improve the understanding of how the 
healing of chronic periodontitis following scaling and root planing 
(SRP) affects GCF ALP activity after 15 days and 60 days in 16 
sytemically healthy patients with moderate to advanced generalised 
chronic periodontitis.  92 pockets were randomized at the split  mouth 
level with half receiving SRP and other half left  untreated. Plaque 
index, probing depth, CAL, BOP were recorded at baseline, after 15 
days and 60 days. GCF was collected from each pocket included in the 
study at the 3 time points for ALP estimation. Results shown a large 
and significant decrease in GCF ALP activity  in 15 days after SRP with 
improvement in clinical parameters after 60 days, an increase in GCF 
ALP back to baseline levels was recorded along with further 
improvements in clinical parameters. Hence, it  was concluded that GCF 
ALP reflects the short term periodontal healing/ recurrent inflammation 
phases in chronic periodontitis patients.  
 
Üsal B et al.,  2008 
33  
 The study aimed at determining the possible relationship between 
alkaline phospahatase levels in the GCF and periodontal disease in men 
Review of Literature 
 
21 
 
with hypergonadotropic hypogonadism (HH) in 41 patients divided into 
4 groups. 9 with HH and periodontitis, 11 with HH and gingivitis,  9 
with systemically healthy and periodontitis,  12 with systemically 
healthy and periodontally healthy individuals. Clinical evaluati on 
included Plaque index, gingival index, probing depth and CAL. The 
ALP IN GCF were measured by ELISA. The concentrations and total 
amounts of ALP in GCF were significantly higher in both periodontitis 
group compared to healthy and gingivitis groups. The serum ALP 
levels were significantly higher in the HH and periodontitis group 
when compared to the other groups. Thus it  was concluded that HH 
could be implicated as a contributing factor to the progress of 
periodontal disease with increased ALP levels.  
 
Malhotra R et al.,  2010 
34  
 The study aimed to assess the total activity of ALP in the GCF 
collected from healthy sites, sites with gingivitis and with chronic 
adult periodontitis along with an attempt made to establish the 
correlation of ALP activity with P laque index, gingival Index, bleeding 
index and probing depth in 18 patients, divided into 3 groups as 
healthy sites-Group I;  Gingivitis- Group II and periodontitis - Group 
III.  ALP levels in GCF of all  the 3 groups was determined by 
spectrophotometric analysis.  The results shown that the total enzymatic 
activity of ALP was significantly higher in periodontitis as compared 
with healthy and gingivitis sites and was positively correlated with 
probing depth. Thus it  was concluded that ALP can be considered as 
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periodontal disease marker as it  can distinguish between healthy and 
inflamed sites.  
 
Perozini C et al.,  2010 
35  
 Evaluated the levels of Interleukin -1β (IL-1β) and ALP in GCF 
and correlate these measurements with clinical characteristics of 36 
individuals subdivided as 3 group healthy individuals and patients with 
gingivitis and periodontitis.  GCF samples were obtained from 2 sites 
for each patient and were measured using Periotron 8000 whereas IL -
1β levels were evaluated using the ELISA and ALP was measure d by 
the kinetic method. The amount of ALP differed significantly among 
the 3 groups. The amount of IL-1β in periodontitis group was 
significantly higher than in the other groups, but no significant 
difference was found between the control group and the gi ngivitis 
group. There was no evidence for correlation between IL -1β and ALP 
levels thus concluding that monitoring immune markers may give 
additional information on healthy or diseased sites.  
 
Jaiswal G et al.,  2011 
3 6  
 The study was carried out to compare  ALP levels in cirrhosis 
patients with and without periodontitis and to correlate ALP levels 
with the severity of periodontitis in 30 liver cirrhosis patients with or 
without periodontitis.  The parameters recorded includes OHI -S index, 
gingival index and CAL along with standardized panaromic radiographs 
to assess alveolar bone height. The total serum ALP level was 
determined with the kinetic method. The alveolar bone loss, CAL and 
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mean serum ALP level in the test group was higher than the control 
group and the difference was statistically significant.  The older age 
group liver cirrhosis patients exhibited higher values for bone loss,  
CAL and serum ALP levels. Hence, it  was concluded that there is a 
strong positive correlation between periodontal breakdown an d serum 
ALP level in liver cirrhosis patients.  
 
Dabra S et al. ,  2012
3 7  
 The purpose of the study was to determine the salivary levels of 
ALP and ACP activities in patients with periodontal disease, before 
and after periodontal treatment. The experimental group consisted of 
20 gingivitis patients, 20 periodontitis patients and the control group 
had 20 healthy subjects. The stimulated saliva was collected and 
analysed using automatic analyser. Periodontal disease was determined 
based on clinical parameters such as gingival index, probing depth and 
CAL. Patients with periodontal d isease were under conventional 
periodontal treatment. The obtained results showed statistically 
significant increased activity of ALP and ACP in saliva from patients 
with periodontal disease in relation to control group and also a 
significant reduction in the enzyme levels after conventional 
periodontal therapy, suggesting that salivary ALP and ACP can be 
considered to be the biomarkers for evaluating periodontal t issue 
damage. 
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Kunjappu JJ et al.,  2012 
38  
 The study compares the levels of GCF ALP in pa tients with 
chronic periodontitis before and after scaling and root planing in 20 
patients with localised periodontitis.  The GCF was collected from the 
affected site prior to scaling and root planing for ALP estimation. The 
probing depth and plaque index a t the sites were also measured at 
baseline, 7, 30 and 60 days for re -assessment. The obtained results 
showed a sustained, statistically significant decrease after treatment 
and thee was a positive correlation with probing depth but not with 
plaque index, measured at each interval. It  was thus concluded that the 
assessment of level of periodontal disease and effect of mechanical 
plaque control on progression and regression of the disease can be 
evaluated precisely by the corresponding GCF ALP levels. Hence, ALP 
level is not only a biomarker for pathology, but also an indicator of 
prognosis of periodontitis.  
 
Trivedi D et al.,  2012 
3 9  
 The study aimed to estimate the LDH, AST, ALP and  CK 
enzymes in unstimulated saliva for valuing their importance as routine 
screening tool in diagnosis of periodontitis in patient group population 
of 205 males and 72 females with mean age of 37.5±6.9 years and 
control group of 95 healthy age matched adult volunteers. Subjects 
having probing depth of >3.5 mm diagnosed as periodont itis. Salivary 
level of LDH, CK, AST, and ALP were measured using commercially 
available kits developed for routine blood test.  The results signified 
increased activities of enzymes in unstimulated saliva, which is either 
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derived from degenerating gingival  t issue or systemic circulation due 
to infectious change in membrane permeability, thus increased levels 
of intracellular enzymes LDH, AST, ALP in unstimulated saliva can be 
used for the diagnostic tool in screening of periodontal disease.  
 
Sanikop S et al .,  2012 
4 0  
 The study aimed to determine the presence and levels of ALP 
activity in GCF in periodontal health, gingivitis and chronic 
periodontitis from 45 sites, which were equally divided into 3 groups. 
Various clinical parameters like Gingival index, pl aque index, probing 
pocket depth, CAL were also evaluated and correlated with the GCF 
ALP levels. The results showed that the difference between the mean 
ALP levels between the healthy and gingivitis group was found to be 
non-significant and that between the chronic periodontitis group and 
healthy as well as gingivitis group was found to be highly significant 
along with significant correlation existing between ALP levels and 
gingival index, probing depth as well as CAL. The findings suggests 
that and confirms the relationship between ALP levels and periodontal 
disease, thus indicating that GCF ALP levels can be used as potential 
biochemical marker for detection and progression of periodontal 
disease. 
 
Ramesh A et al.,  2013 
5  
 The study aimed at the estimation of salivary ALP levels in 40 
subjects, 20 in each groups in the age group of 50 - 60 years. Group I is 
of 20 post-menopausal women without chronic periodontitis and group 
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II of 20 post-menopausal women with chronic periodon titis.  The results 
shown significant increase in alkaline phosphatase in post -menopausal 
women with chronic periodontitis. Hence it was concluded that ALP 
can be used as a diagnostic marker of periodontitis in post -menopausal 
women; however ALP cannot sole ly be responsible for periodontitis, 
but i t  can be used as an addition aid in diagnosing periodontitis.  
 
Khongkhunthian S et al.,  2014 
4 1  
 The study compared two biochemical markers Chondroitin 
sulphate (CS) and alkaline phosphatase (ALP) levels in GCF sam ples 
collected from patients with various degrees of disease severity. The 
samples includes 10 patients with gingivitis (50 sites);  33 patients with 
chronic periodontitis (50 sites) as well as 10 healthy volunteers (50 
sites) by periopaper strips and level s of CS and ALP measured by an 
ELISA and a fluorometric assay. The results demonstrated low levels 
of CS and ALP in non-destructive and slightly destructive periodontitis 
sites, whereas significantly high levels in moderately and severely 
destructive sites . Stronger correlates were found between CS levels and 
periodontal parameters including probing depth, loss of clinical 
attachment levels, gingival index and plaque index, than between ALP 
levels and these parameters suggested that CS level is a better 
diagnostic marker than ALP level for evaluating disease severity of 
chronic periodontitis.  
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Perumal CL et al.,  2014 
42  
 The study was carried out to compare the serum total ALP level 
among 31 healthy individuals and 36 chronic periodontitis patients in 
Tamilnadu and to evaluate the racial behaviour in the enzyme levels.  
Comparison of the total ALP activity between the healthy and chronic 
periodontitis group showed an increase in total ALP activity among 
chronic periodontitis.  Thus, the results were simil ar to other studies, 
suggestive of using serum ALP measurement as a reliable assay for 
chronic periodontitis and there was no racial or ethnic differences.  
 
Caúla AL et al.,  2015 
4 3  
 The study aimed to evaluate the relationship between severe 
chronic periodontitis and serum creatinine and ALP levels. 100 patients 
were evaluated, 66 with severe chronic periodontitis and 34 
periodontally healthy individuals. Blood samples were collected after 
an overnight fast and serum creatinine and ALP levels were 
determined. The results showed that the patients with periodontitis 
exhibited a lower mean creatinine level and higher mean alkaline 
phosphatase levels than in control group. Also there was significant 
correlation between the periodontal parameters and serum creat inine 
and ALP levels. Hence it  was concluded that severe chronic 
periodontitis was associated to lower creatinine and higher ALP levels.  
 
Luke R et al. ,  2015 
4 4  
 The study aimed to estimate the levels of enzymes AST, ALT, 
ALP and BUN in saliva and to corre late it  with that of clinical 
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parameters to saliva of healthy subjects, gingivitis patients and patients 
with chronic periodontitis.  The study included 40 male subjects of age 
group 21 to 50 years. Clinical parameters like OHI -S, sulcus bleeding 
index, probing depth, CAL and periodontal index were recorded. The 
results showed significant increase of activity of AST, ALT, ALP and 
BUN in saliva from patients with periodontal disease in relation to 
gingivitis and control group. There was also an increase in pe riodontal 
parameters with an increase in salivary enzymes. Thus it  was 
concluded that salivary enzymes can be used as biomarker to determine 
periodontal tissue damage, which may be useful in diagnosis, prognosis 
and evaluation of post therapy effects in pe riodontal disease.  
 
Soud P et al. ,  2015 
4 5  
 The study aimed to determine the enzyme and mineral activity in 
serum of subjects with chronic periodontitis namely ALP, ACP, Ca and 
K in 30 patients. Blood samples were taken to assess the levels of 
enzymes and minerals.  Periodontal disease was identified clinically by 
assessing probing depth and CAL. Amount of bone loss was confined to 
radiographic evaluation. The results showed that the periodontitis 
patients had high level of ALP which indicates statistically significant 
results as compared to ACP levels, which had no significance with the 
results.  From this study, it  was concluded that serum level of ALP was 
significantly elevated in patients with chronic periodontitis and can be 
considered as a biomarker for periodontal disease activity.  
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MATERIALS AND METHODS 
 
A clinical study was conducted at the department of 
periodontology, Adhiparasakthi dental college and hospital 
(APDC&H), Melmaruvathur . A total number of 50 subjects in the age 
range of 30 to 50 years were selected from the out -patient division of 
Periodontics, APDC&H. Ethical clearance for the study was obtained 
from the Institutional review board, APDC&H (Reference No:2014 -
MD-BrII-SAS-05). All the subjects participated in the study were 
informed about the nature of the study and all  the participants signed 
an informed consent form.  
 
Method: 
Sample size:  
  Control Group:10 individuals (periodontally healthy individuals)  
  Study Group:40 patients (chronic generalised periodontitis)  
 
Inclusion criteria:  
  Control group: Participants with at least 20 natural teeth and 
probing pocket depth of 2-3mm with no attachment loss and 
bleeding on probing with< 20% sites.  
  Study group: Participants had to have 5 qualifying sites in 2 
quadrants with a minimum of 2 affected teeth in each quadrant 
with each site having probing depth ≥5mm, CAL ≥3mm, bleeding 
on probing. 
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Exclusion criteria:  
  Any systemic diseases  
  Smokers 
  Pregnancy 
  Has not undergone any periodontal therapy for the past 1 year.  
  Patients who are not maintaining their oral hygiene.  
 
The following clinical indices and parameters were recorded:  
  OHI-S Index(Greene & Vermillion)  
  Gingival Index(Loe&Silness)  
  Probing pocket depth  
  CAL  
 
The following biochemical markers were analysed:  
  Salivary ALP level  
  Serum ALP level  
 
Method to be followed:  
 After getting the informed consent signed, all  the individuals 
participated in the study were subjected to measurement of clinical 
indices including OHI-S and Gingival Index and clinical parameters 
including Probing depth and CAL at baseline for the study group, 
followed by saliva and blood sample collection for both study and 
control groups, which was then analysed for ALP estimation. Following 
sample collection, complete ultrasonic scaling to be performed at day 1 
for patients under study group (Chronic p eriodontitis).  Complete Root 
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planing should be completed within 15 days from the baseline in two 
subsequent visits.  On 30
t h
 day after completion of phase 1 periodontal 
therapy, patients are reviewed where saliva and blood samples are 
collected and analysed again for ALP activity.  
 
OHI-S (Greene and Vermillion, 1964)
 4 6  
The Simplified Oral Hygiene Index (OHI -S) differs from the 
original OHI (The Oral Hygiene Index) in the number of the tooth 
surfaces scored (6 rather than 12), the method of selecting the surfaces 
to be scored, and the scores, which can be obtained. The criteria used 
for assigning scores to the tooth surfaces are the same as those use for 
the OHI (The Oral Hygiene Index).  
 
The OHI-S, like the OHI, has two components, the Debris Index 
and the Calculus Index. Each of these indexes, in turn, is based on 
numerical determinations representing the amount of debris or calculus 
found on the preselected tooth surfaces.  
 
Selection of tooth surfaces  
 The six surfaces  examined for the OHI-S are selected from four 
posterior and two anterior teeth.  
  In the posterior portion of the dentition, the first  fully erupted 
tooth distal to the second bicuspid (15), usually the first  molar 
(16) but sometimes the second (17) or third molar (18), is 
examined. The buccal surfaces of the selected upper molars and 
the lingual surfaces of the selected lower molars are inspected.  
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  In the anterior portion of the mouth, the labial surfaces of the 
upper right (11) and the lower left  central incisors (31) are scored. 
In the absence of either of this anterior teeth, the central incisor 
(21 or 41 respectively) on the opposite side of the midline is 
substituted.  
 
Criteria for classifying debris  
Scores Criteria 
0 No debris or stain present  
1 Soft debris covering not more than one third of the tooth 
surface, or presence of extrinsic stains without other 
debris regardless of surface area covered  
2 Soft debris covering more than one third, but not more 
than two thirds, of the exposed tooth surface.  
3 Soft debris covering more than two thirds of the exposed 
tooth surface.  
 
Criteria for classifying calculus  
Scores Criteria 
0 No calculus present  
1 Supragingival calculus covering not more than third of 
the exposed tooth surface.  
2 Supragingival  calculus covering more than one third but 
not more than two thirds of the exposed tooth surface or 
the presence of individual flecks of subgingival calculus 
around the cervical portion of the tooth or both.  
3 Supragingival calculus covering more than two  third of 
the exposed tooth surface or a continuos heavy band of 
subgingival calculus around the cervical portion of the 
tooth or both.  
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Interpretation  
Individually DI-S and CI-S is scored as follows:  
0.0 to 0.6 = Good oral hygiene  
0.7 to 1.8 = Fair oral hygiene  
1.9 to 3.0 = Poor oral hygiene  
 
An OHI-S is scored as follows:  
0.0-1.2 = Good oral hygiene  
1.3 -3.0 = Fair oral hygiene  
3.1 -6.0 = Poor oral hygiene 
 
Oral Hygiene Index = Debris Index + Calculus Index 
 
Gingival Index: 
47  
Gingival Index (GI) was introduced by Loe and Silness  in 1963 
  GI could be used in all  teeth or selected teeth and in all  surfaces 
or selected surfaces.  
  The examination done by blunt probe.  
  Partially erupted teeth, retained roots, teeth with periapical 
lesion and third molars should be excluded and there is no 
substitution.  
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Calculation:  
GI = Total scores /  No. of surfaces examined  
 If we want to calculate the maximum score for gingival index (4 
surfaces and 6 teeth)  
 
Interpretation:  
Score Criteria 
0 - No inflammation.  
1 - Mild inflammation, slight change in color, slight edema,  
  no bleeding on probing.  
2 - Moderate inflammation, moderate glazing, redness,  
  bleeding on probing. 
3 - Severe inflammation, marked redness and hypertrophy,  
  ulceration, tendency to spontaneous  bleeding. 
 
GI is scored as follows:  
0.1-1:  Mild gingivitis  
1.1- 2:  Moderate gingivitis  
2.1- 3:  Severe gingivitis  
 
Probing pocket depth (PD):
 48  
 Probing depth is a measurement of the depth of a sulcus or 
periodontal pocket.  It  is determined by measuring the distance from the 
gingival margin to the base of the sulcus or pocket with a calibrated 
periodontal probe. Probing involves "stepping" a calibr ated periodontal 
probe (UNC-15) around the tooth and recording the deepest point at 
each of six tooth surfaces: distofacial, facial,  mesiofacial, distolingual, 
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lingual,  and mesiolingual.  As a general rule, a probe reading that falls  
between two calibrated marks on the probe should be rounded upward 
to the next highest millimetre. Out of 6 surfaces per tooth, the highest 
probing depth value is taken as the probing depth of that individual 
tooth.  
 
Clinical Attachment Level (CAL): 
48  
CAL is the distance from the cementoenamel junction (CEJ) to 
the base of the periodontal pocket.  CAL measurement also involves 
measuring with a calibrated periodontal probe (UNC -15) around the 
tooth and recording the deepest point at each of six tooth surfaces from 
the CEJ: distofacial,  facial, mesiofacial,  distolingual,  lingual,  and 
mesiolingual.  
 
Collection of saliva:  
 All thePatients in the study were asked to rinse with normal 
water (to wash out exfoliated cells) and then wait for 5 minutes. 5 ml 
of unstimulated saliva was collected from each patients between 
9.00am to 11.00am as method given by Navazesh M 1993.
49  
Unstimulated saliva was collected by the spit  method in a sterile 
sample collection container. The saliva sample was sent to the lab 
immediately where it  was centrifuged at 3000rpm for 5 minutes and 
then the ALP enzyme activity in saliva was determined 
spectrophotometrically with the help of a semi -autoanalyser (BTS 350, 
BIOSYS®) with the IFCC recommendations.  
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Collection of blood:  
 5ml of fasting blood samples were collected from each 
individuals transferred to the nearby biochemical laboratory for assay. 
After an hour, the supernatant serum was extracted and Total ALP 
levels were evaluated semi-autoanalyser (BTS 350, BIOSYS®) with the 
IFCC recommendations and the results expressed in U/L.  
 
Non-surgical periodontal therapy:  
 Following the sample collections, complete ultrasonic scaling 
was performed to all  the patients in study group. All the patients were 
instructed to maintain their oral hygiene with M odified Bass brushing 
technique and to use Chlorhexidine mouth wash twice daily. Root 
planing, wherever required was done after 15days from baseline within 
2 subsequent visits.  All the patients were recalled on 30
t h
 day 
following completion of phase 1 periodontal therapy for review and 
post-operative sample collection (both blood and saliva).  
 
ALP ESTIMATION BY SPECTROMETRY:  
Method: 
Kinetic photometric test, according to the International 
Federation of Clinical Chemistry and Laboratory Medicine (IFCC).  
 
Principle: 
p-Nitrophenylphosphate + H 20              Phosphate + p-Nitrophenol  
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Reagents: 
Components and Concentrations:  
R1:    2-Amino-2-methyl-1 -propanol pH 10.4  1.1 mol/L 
Magnesium acetate       2 mmol/L 
Zinc sulphate       0.5 mmol/L 
HEDTA             2.5 mmol/L 
R2:     p-Nitrophenylphosphate      80 mmol/L 
 
Storage Instructions and Reagent Stability:  
 The reagents are stable upto the end of the indicated month of 
expiry, if stored at 2-8 °C and contamination is avoided.  
 
Reagent Preparation:  
Substrate Start  
 The reagents are ready to use.  
 
Sample Start  
Mix 4 parts of R1 + 1 part of R2 (e.g. 20 mL R1 + 5 ml_ R2) = 
monoreagent 
Stability:        
4 weeks            at               2-8 °C 
5 days               at            15-25°C 
Specimen 
Stability:        
7 days            at           20-25°C 
7 days            at             4 -  8 °C 
2 months        at             -20 °C 
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Sample start 
                                                    Blank        Sample or calibrator  
Sample or calibrator                       -             20 μL  
Dlst. Water                                    20 μL                       -    
I Monoreagent          1000 μL       1000 μL  
 
 Mix, read absorbance after 1 min. and start  stopwatch. Read 
absorbance again after 1, 2 and 3 min.  
 
Performance characteristics  
Measuring range  
 On automated systems the test is suitable for the determination 
of AP activities up to 1400 U/L.  
 
 In case of a manual procedure, the test is suitable for AP 
activitieswhich correspond to a maximum of AA/min of 0.25.  
 
 If such values are exceeded the samples should be diluted 
1+9with NaCl solution (9 g/L) and results multiplied by 10.  
 
Specificity/Interferences:  
 No interference was observed by ascorbic acid up  to 30 mg/dL, 
conjugated bilirubin up to 60 mg/dL, unconjugated bilirubin to 25 
mg/dL, hemoglobin up to 100 mg/dL and lipemia up to 2000 mg/dL 
triglycerides.  
 
Sensitivity/Limit of Detection:  
 The lower limit of detection is 2 U/L.  
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Basic Armamentarium:  
1. Mouth mirror  
2. UNC 15 probe  
3. Universal curettes- 2R/2L & 4R/4L  
4. Gracey curettes- #1-14  
5. Surgical gloves  
6. Mouth masks  
7. Tweezers  
8. Cotton rolls  
9. 5 ml sterile saliva collection containers  
10.2 ml blood collection sample tubes  
11.ALP enzyme kit .  Diasys® ALP 
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Figure 1: Chronic generalised periodontitis Pre -operative 1 
 
 
Figure 2: Chronic generalised periodontitis Pre -operative 2 
 
 
Figure 3: Chronic generalised periodontitis Pre -operative 3 
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Figure 4: Probing depth >5mm at baseline  
 
 
Figure 5: Following non-surgical therapy 1 
 
 
Figure 6: Following non-surgical therapy 2 
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Figure 7: Following non-surgical therapy 3 
 
 
Figure 8: Probing depth after phase 1 periodontal therapy  
 
 
Figure 9: Collection of blood (I.V)  
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Figure 10: Collection of saliva 
 
 
Figure 11: Collected blood sample  
 
 
Figure 12: Collected saliva sample  
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Figure 13: Centrifuge machine  
 
 
Figure 14: Centrifuged saliva and serum samples  
 
 
Figure 15: ALP kit (Diasys®)  
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Figure 16: Semi auto analyser for ALP estimation  
 
 
Figure 17: Armamentarium 
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RESULTS 
 
This study was conducted to evaluate the levels of serum and 
salivary ALP in patients with generalized chronic periodontitis  before 
and after non-surgical periodontal therapy and to compare the 
outcomes with healthy subjects. A total of 40 chronic generalised 
periodontitis (study group) and 10 periodontally healthy subjects 
(control group) were selected from the out -patient section of 
department of periodontics, Adhiparasakthi dental college and hospital.  
All clinical parameters were measured at baseline with saliva and 
blood samples collected on the same day and then 30 days after phase 1 
periodontal therapy. Saliva and blood s amples were sent for 
spectrometric analysis for ALP estimation. The obtained results were 
tabulated and the data collected were subject to statistical analysis.  
 
STATISTICAL ANALYSIS:  
 The collected data was subjected to statistical analysis through 
SPSS (Statistical Package for Social Science).  
  
 The Paired t test  was used to assess the baseline and post -
operative values of clinical parameters such as OHI -S, Gingival index, 
probing pocket depth, Clinical Attachment Level and biomarker 
parameters such as serum ALP and salivary ALP levels.  
  
 The paired samples correlations (Paired t test) was used to 
assess the correlation between clinical parameters such as OHI -S, 
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Gingival index, probing depth, CAL and biomarker parameters such as 
serum ALP and salivary ALP levels.  
  
 The One way ANOVA was used to compare the enzyme levels in 
saliva and serum between the study group at baseline, post -operatively 
and control group.  
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Table 1: Mean change in OHI-S score from baseline to post -
operative in study group 
 
 
 
 
 
Significant at the 1% level.  **Statistically highly significant difference  
 
The mean OHI-S score of study group at baseline was 3.00 ± .04  
and post-operative score was found to be 99 ± .02 .  On comparing 
baseline score with post -operative score, the reduction in the OHI -S 
score was found to be statistically significant with P -value .000** 
 
Chart 1: Mean change in OHI-S score from baseline to post-
operative in study group 
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Table 2: Mean change in GI score from baseline to  
post-operative in study group 
 
Significant at the 1% level.  **Statisticall y highly significant difference 
 
The mean GI score at baseline in study group was 1.97 ± .05  and 
post-operative score was found to be .61 ± .01 .  On comparing baseline 
score with post-operative score, the reduction in the GI score was 
found to be statistically significant with P-value .000** 
 
Chart 2: Mean change in GI score from baseline to  
post-operative in study group 
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Table 3:  Mean change in probing depth & CAL from baseline to 
post-operative in study group 
 Baseline Post-operative T value P-value 
PD 3.63 ± .17mm 1.93 ± .09mm 17.88 .000** 
CAL 4.14 ± .19mm 2.23 ± .09mm 18.58 .000** 
 
Significant at the 1% level.  **Statistically highly significant difference  
  
 The mean probing depth & CAL in study group at baseline was 
3.63 ± .17mm  and 4.14 ± .19mm  respectively and post -operatively 1.93 
± .09mm  and 2.23 ± .09mm .  On comparing baseline values with  
post-operative values, the reduction in the probing depth and gain in 
CAL post-operatively was found to be statistically significant with P -
value .000**. 
 
Chart 3: Mean change in probing depth & CAL from baseline to 
post-operative in study group 
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Table 4: Comparison of mean baseline salivary & serum ALP levels 
between control group and study group  
 
Significant at the 1% level.  **Statistically highly significant difference  
 
On Comparing the mean baseline values of salivary andserum  
ALP levels of control group with baseline values of study group, the 
difference in salivary and serum ALP levels between control group 
(23.00 ± 6.67 and 72.70 ± 2.19) and study group (79.55 ± 6.40 and 
97.62 ± 4.17) was found to be statistically significan t with P-value of 
.000** and .009** for saliva and serum respectively.  
 
 
 
 
 
 
 
 
 
 
 Control group Study group F value P-value 
Saliva ALP 23.00 ± 6.67 79.55 ± 6.40 13.36 .000** 
Serum ALP 72.70 ± 2.19 97.62 ± 4.17 4.95 .009** 
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Table 5: Comparison of mean baseline salivary & serum ALP values 
with post-operative ALP values of study group 
 
Significant at the 1% level.  **Statistically highly significant difference  
 
On Comparing the mean baseline salivary and serum ALP values 
with post-operative values in study group, the difference in salivary 
and serum ALP levels from baseline (79.55 ± 6.40 and 97.62 ± 4.17) to 
post-operative (49.47 ± 5.11 and 85.40 ± 4.10) was found to be 
statistically significant with P-value of .000** and .009** for saliva 
and serum respectively. 
 
 
 
 
 
 
 
 
 
 Baseline 
Post-
operative 
F 
value 
P-value 
Saliva ALP 79.55 ± 6.40 49.47 ± 5.11 13.36 .000** 
Serum ALP 97.62 ± 4.17 85.40 ± 4.10 4.95 .009** 
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Table 6: Comparison of mean baseline salivary & serum ALP values 
of control group with post -operative ALP values of study group 
 
 
Significant at the 1% level.  **Statisticall y highly significant difference  
 
On Comparing the mean baseline salivary and serum ALP values 
of control group with post -operative values of study group, the 
difference between the ALP levels in baseline of control group (23.00 
± 6.67 and 72.70 ± 2.19) to post -operative of study group (49.47 ± 5.11 
and 85.40 ± 4.10) was found to be statistically significant with P -value 
of .000** and .009** for saliva and serum respectively.  
 
 
 
 
 
 
 
 
 Control group 
Study group 
Post-operative 
F 
value 
P-value 
Saliva ALP 23.00 ± 6.67 49.47 ± 5.11 13.36 .000** 
Serum ALP 72.70 ± 2.19 85.40 ± 4.10 4.95 .009** 
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Chart 4: Comparison of mean salivary ALP levels in control group 
with baseline and post -operative ALP levels of study group  
 
 
 
Chart 5: Comparison of mean serum ALP values in control group 
with baseline and post -operative ALP levels  of study group 
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DISCUSSION 
 
A comparative clinical study was conducted in department of 
Periodontology, APDCH, Melmaruvathur, Tamilnadu . The study 
population consists of 50 participants of which, 40 patients with 
chronic generalised periodontitis (Study group) and 10 periodontally 
healthy individuals (Control group) were included in the study to whom 
the study design was explained and informed consent was obtained 
from all  the patients included in the study. Clinical indices including 
OHI-S, Gingival Index and clinical parameters including Probing 
depth, CAL were measured at baseline and following phase 1 
periodontal for the study group. No clinical parameters were evaluated 
for the control group, since the control group exhibited <20% of sites 
bleeding on probingand probing pocket depth of 2-3mm and no 
attachment loss,  along with good oral hygiene maintenance.  
 
Alkaline phosphatase (ALP) l evels in serum and saliva were 
evaluated by collecting the blood and saliva samples from 
periodontally healthy individuals once and at baseline and then 
following phase 1 periodontal therapy in patients with chronic 
generalised periodontitis.  
 
The term ‘biomarker’ refers to biologic substances that can be 
measured and evaluated to serve as indicators of biological health,  
pathogenic processes, environmental exposure and pharmacologic 
responses to a therapeutic intervention. 
50  
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Therefore, better understanding and thorough knowledge of the 
biomarkers of health and disease leads to enhanced execution of 
appropriate and personalized preventive and therapeutic strategies to 
maintain finest health of an individual.  
 
Periodontal pathogenic processes can  be generally divided into 
three phases: inflammation; connective tissue degradation; and bone 
turnover. During each phase of the disease, specific host -derived 
biomarkers have been identified and therefore provide a general sense 
of stage of pathologic process the patient is currently undergoing.  
 
Among several biomarkers of periodontal disease activity, 
alkaline phosphatase, being a phenotype marker of bone turnover rate 
has been found to be elevated in a variety of bone disorders with the 
highest elevations occur in Paget’s disease (osteitisdeformans). Other 
bone disorders including osteomalacia, rickets, hyperparathyroidism, 
and osteogenic sarcoma have also shown elevated levels of ALP. In 
addition, increased levels are also seen in the case of healing b one 
fractures and during periods of physiologic bone growth.  
 
In the past few years, various cross sectional clinical studies in 
humans have been conducted and proved the robust relationship 
between the periodontitis and elevated ALP levels in serum and in  
GCF.
3 ,  8 ,  9  
Though predictable, the sampling of blood by intravenous 
method is invasive and causes discomfort to the patients, its use for 
periodontal disease is of less patient compliance. And though reliable, 
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sampling from GCF is technique sensitive and  takes longer time 
comparatively with the sample collection time for saliva.  
 
Saliva, rich in serum albumin and in antimicrobial and immuno -
modulary proteins, subsidise the lubrication of oral cavity, buffering of 
the tooth surface thus maintaining the int egrity of the oral cavity. 
Saliva also contains non-salivary elements, such as gingival crevicular 
fluid, desquamated cells,  nasopharyngeal discharge, extraneous debris,  
and bacteria and bacterial by-products.  
51  
 
Numerous advantages lies in choosing saliva as a diagnostic tool 
which includes its readily available nature, it  can be collected in a 
comfortable manner unlike blood collection by venepuncture and the 
associated fear of the needle, whereas saliva can be c ollection in a non-
invasive manner, which makes patient compliance a reliable factor.  
 
Various studies in the past few years have revealed the potential 
to identify and measure numerous biomarkers in saliva for the 
diagnosis of periodontal diseases and mon itoring its progression and 
health. 
 
The study conducted by Miglani D C et al. ,  in 1974 
28
 revealed 
the relationship between periodontal disease and ALP levels in saliva 
was the first  study in Indian population, correlating the Periodontal 
disease status with salivary ALP levels. Later, studies by Todorovic T 
et al. ,  in 2006 
7  
showed that the activity of ALP along with various 
other enzymes in saliva was increased in patients with periodontal 
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disease with a positive correlation with gingival index, when com pared 
with periodontally healthy individuals. Further study by Desai S et al. ,  
in 2008 
31  
evaluated ALP levels in unstimulated saliva of 120 patients 
with chronic periodontitis which were correlated with CPITN index. 
The study results showed that the ALP l evels in saliva was increased 
with the increase in the CPITN score.  
 
Dabra S et al. ,  in 2012 
37  
evaluated the  salivary levels of ALP 
activity in patients with periodontal disease, before and after 
periodontal treatment resulted that there was significantly  increased 
activity of ALP in saliva from patients with periodontal disease and 
also a significant reduction in the enzyme levels after conventional 
periodontal therapy.  
 
Trivedi D et al.,  in 2012 
3 9  
estimated the ALP level along with 
other enzymes in unst imulated saliva for the diagnosis of periodontitis 
in patients with chronic periodontitis and healthy individuals. The 
results of the study signified increased activities of ALP and other 
enzymes in unstimulated saliva of patients with chronic 
periodontitis.Study by  Ramesh A et al.,  in 2013 
5  
estimated the 
salivary ALP levels in post -menopausal women with and without 
chronic periodontitis and the results showed a significant increase in 
salivary ALP levels in post -menopausal women with chronic 
periodontitis . Later,  Luke R et al. ,  in 2015 
44  
estimated the levels of 
ALP along with other few enzymes in saliva and correlated it  with that 
of clinical parameters in healthy subjects, gingivitis patients and 
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patients with chronic periodontitis and the results showed  significantly 
increased activity of ALP along with the other enzymes in saliva from 
patients with periodontal disease than that of gingivitis and control 
group.  
  
 All the studies conducted so far has aimed to rationalise the use 
of ALP as a biomarker in diagnosing the disease activity of 
periodontitis. The studies also have established the use of either saliva 
or serum or even GCF solely in evaluating the ALP levels in patients 
with chronic periodontitis and even comparison of the same with 
periodontally healthy individuals. But none of the studies have 
compared the serum and salivary ALP levels in chronic periodontitis 
patients and periodontally healthy individuals of same age group to 
validate the fact that saliva could be used over serum and GCF to 
assess the disease activity in patients with chronic periodontitis and 
also its significance of increased activity with periodontally healthy 
individuals.  
  
 Hence, the present study was conducted to compare and evaluate 
the ALP levels in serum and saliva in patients with chronic 
periodontitis and to compare the ALP levels with that of the healthy 
individuals. All clinical parameters including probing depth, CA L and 
indices including OHI-S and GI, along with serum and salivary samples 
were collected at baseline, and then 30 days after completion of phase 
1 periodontal therapy.  
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 The results indicated that there was a significant reduction in the 
mean OHI-S scores in the chronic periodontitis group from baseline to 
30 days from 3.00 ± .04 to .99 ± .02 post-operatively. This implies the 
good oral hygiene maintenance of the patient following periodontal 
phase 1 therapy, which is of utmost importance factor in the p rognosis 
of the treatment outcomes.  
  
 There is a significant reduction in the mean Gingival Index 
scores from baseline to 30 days from 1.97 ± .05 to .61 ± .01 following 
periodontal phase 1 therapy which is in accordance with the study 
conducted by Todorovic T et al. ,  in 2006 .  
7
 This may be due to the 
elimination of local etiological factors which harbours numerous 
pathogenic strains  
 
There is a significant reduction in mean probing pocket depth 
readings from baseline to 30 days from 3.63 ± .17mm to  1.93 ± .09mm 
following periodontal phase 1 therapy. This can be attributed to the 
scaling and root planing, as it  leads to resolution of inflammatory 
response and cessation of periodontal disease progression, thereby 
resulting in reduction of probing depth which  is in accordance with the 
studies conducted by Daltaban Ö et al.,  2006 
30
 and Todorovic et al.,  
2006. 
7  
 
There is a significant reduction in mean CAL readings from 
baseline to 30 days from 4.14 ± .19mm  to 2.23 ± .09mm following 
periodontal phase 1 therapy which is in accordance with the study done 
by Dabra S et al. ,  2012. 
3 7  
The CAL gain may be due to effectiveness 
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of Scaling and root planing as it  leads to resolution of inflammatory 
response and cessation of periodonta l disease progression and hence 
resulting in a relative gain of clinical attachment level.  Scaling and 
root planing also helps in eliminating the bacteria present at the site, 
thus reducing the colonization of periodontal pathogens resulting in 
making a favourable environment for oral hygiene maintenance by the 
patient.  
 
Following phase 1 periodontal therapy, the patients with chronic 
periodontitis has shown a proportionate reduction in the ALP mean 
values in both saliva (79.55 ± 6.40  to 49.47 ± 5.11) and serum (97.62 ± 
4.17  to 85.40 ± 4.10) respectively. The reduction in the values may be 
due to thorough scaling and root planing with proper oral hygiene 
maintenance of the patients. The results of this study is in accordance 
with the results obtained from the study conducted by Dabra S et al.,  
in 2011 
37  
for salivary ALP levels at baseline and post -operatively,  
which was  (29.43±13.10 to 44.55±19.14). 
 
In the present study, treatment instituted for the patients with 
chronic periodontitis  which included scaling and root planing. 
Following phase 1 periodontal therapy, all  the patients received oral 
hygiene instructions for home care plaque control, which lead to 
improvement in clinical parameters. Along with the clinical 
parameters, the sal ivary and serum ALP levels were shown to be 
decreased significantly following phase 1 periodontal therapy due to 
the reason that the collagen breakdown and alveolar bone resorption 
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caused by the active inflammation gets subsided with reduction in 
inflammation following phase 1 periodontal treatment. In addition to 
the salivary and serum ALP levels obtained from chronic periodontitis  
group, both serum and salivary ALP levels were also evaluated in 10 
periodontally healthy volunteers with no clinical signs of  gingival or 
periodontal disease, which were 23.00 ± 6.67  for saliva and 72.70 ± 
2.19  for serum which was found to be statistically significant when 
compared with the mean values of the baseline of chronic periodontitis 
group with the P-value of .009** and .000** for saliva and serum 
respectively.  
 
Utilization of saliva as diagnostic fluid has got various 
advantages like painless technique, non -invasive, ease of collection 
and storage, cost -effective and readily available for any diagnostic 
purposes. Hence,  in the present study, saliva have been chosen to 
evaluate the ALP levels and to compare the values with that of serum 
to validate that saliva could be chosen over serum for biomarker 
evaluation.  
 
In addition, we chose ALP as a periodontal disease marker 
because of its role potential behaviour in the periodontal disease 
progression of an individual. ALP levels were found to be higher 
during collagen breakdown and alveolar bone resorption caused by 
periodontal disease. Various clinical studies have proved th e beneficial  
outcome of choosing ALP as periodontal disease marker and its good 
predictable value. Also, the evaluation of ALP in laboratory is cheaper 
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and the method of evaluation by spectrophotometry is made simplified 
by the advances in equipment to auto/ semi-auto analyser. Hence, ALP 
can be used to rule out the periodontal disease activity in a short  
period of time. Another advantage of electing ALP as a biomarker of 
periodontal disease progression is because of its low cost, which will  
be much useful for patients with poor socio-economic status.  
 
The results of the present study signifies that there is substantial 
improvement in the mean values of clinical indices which includes 
OHI-S, Gingival Index, clinical parameters including Probing pocket 
depth,  CAL following phase 1 periodontal therapy that includes 
complete scaling and thorough root planing. Interestingly, the mean 
ALP values in both saliva and serum also exhibited significant 
reduction following the phase 1 periodontal therapy, which shows a 
positive correlation with the mean values of clinical parameters and 
indices.  
 
On comparing the mean baseline salivary and serum ALP values 
with post-operative ALP values in study group, the difference in 
salivary and serum ALP levels from baseline to post -operative was 
found to be statistically significant. The mean ALP values in saliva  and 
serum of control group (periodontally healthy individuals) when 
compared to the study group (chronic generalised periodontitis) the 
difference in ALP levels in both base line and post-operatively was also 
found to be statistically significant.  
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This is the first  study to compare and evaluate the ALP levels in 
saliva and serum in patients with chronic generalised periodontitis and 
to compare the ALP levels with that of the healthy individuals. In 
addition, the clinical indices including OHI -S, GI, and clinical 
parameters including probing depth and CAL was also compared for the 
patients with chronic generalised periodontitis at baseline and after 
phase 1 periodontal therapy to evaluate the treatment outcomes 
following phase 1 periodontal therapy in chronic periodontitis patients.  
 
With the results of the present study, i t  could be suggested that 
salivary ALP levels could be used instead of serum ALP levels to 
evaluate the periodontal disease activity in patients with chronic 
generalised periodontitis. Further studies with large population size 
should be conducted to synergize the outcome of the present study.  
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CONCLUSION 
 
The traditional method of diagnosing periodontitis  one includes 
assessment of clinical parameters and radiographic aids to evaluate the 
periodontal tissue destruction.  
 
However screening and diagnostic modalities for the early 
identification of periodontitis is not significant through the 
conventional diagnostic method, a need for evolution of reliable 
diagnostic methods to rule out periodontal disease in the early stage of 
the disease progression lead to the emergence of biomarkers in the 
field of diagnosis.  
 
So far,  several inflammatory and immune media tors have been 
implicated as biomarkers in the periodontal t issue destruction in both 
saliva and serum and shown its clinical predictability of recognizing 
disease activity  
 
Alkaline phosphatase (ALP), being a hydrolase enzyme which is 
also considered as a phenotypic marker is a major destructive enzyme 
involved and expressed in high concentrations during the degradation 
and remodelling of alveolar bone and collagenase activity of the 
periodontium 
 
Evaluation of ALP by simplified method of spectrometry and  its 
cheaper analysis cost makes the biomarker ALP as a resilient and 
reliable one for the diagnosis of periodontal disease activity for any 
individual  
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Serum has the potential to be used as the diagnostic fluid for oral 
diseases and is usually used for t he detection of active face of 
periodontal disease to identify individuals at higher risk for future 
disease occurrence. With the advent of highly sensitive techniques, 
traces of markers can be accurately established in serum  
 
Saliva has the potential to be used as the diagnostic fluid for oral 
disease. Its easy method of collection through non -invasive methods, 
without specialized equipment or personnel, and also contains locally 
derived and systemically derived markers and also its readily 
availability makes saliva to choose over serum for the evaluation of 
biomarkers  
 
The results of present study shown that  
1. ALP levels in saliva  and serum were increased in patients with 
chronic generalized periodontitis when compared with 
periodontally healthy individuals.  
2. The increase in the salivary and  serum ALP levels were 
positively correlated with the clinical indices and parameters 
including OHI-S, Gingival index, probing depth and CAL in 
study group. 
3. Following the phase I periodontal treatment t here was a 
significant decrease in the salivary and  serum ALP levels in 
patients with chronic generalized periodontitis along with 
improvement in the clinical parameters.  
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4. The ALP activity during disease progression and following phase 
I periodontal treatment in saliva and serum were also positively 
correlated with respect to disease course.  
 
 With the limitations of the present study it  could be concluded 
that ALP levels in saliva could be evaluated for the diagnosis of active 
phase of periodontal disease and also for evaluation of the treatment 
outcomes following periodontal phase I therapy. Further study with 
large sample size and with different duration of ALP estimation in 
saliva should be done to support the evidence of the present study.  
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Annexure 
 
i 
 
PROFORMA 
 
EVALUATION OF SERUM AND SALIVARY ALKALINE PHOSPHATASE 
LEVELS IN PATIENTS WITH CHRONIC PERIODONTITIS BEFORE AND 
AFTER NON-SURGICAL PERIODONTAL THERAPY: A COMPARATIVE 
STUDY 
 
S.no:                               OP.No:                                   Date: 
Name:                                            Age:                  Gender:                   Address: 
 
Occupation: 
Chief complaint: 
 
History of presenting illness: 
 
Past medical history:  
Overall systemic health status report from General medicine OPD: 
Past dental history: 
Personal history: 
1. Oral hygiene measures: 
 
 
2. Habits: 
Intra-Oral examination: 
Missing teeth: 
Dental caries: 
Annexure 
 
ii 
 
Clinical Parameters (Baseline) 
Indices: 
OHI-S Index: (Greene & Vermillion-1964) 
Debris        
Tooth  16 11 26 36 31 46 
Calculus       
Debris Index =          / 6 =  
Calculus Index =          / 6 =  
Oral Hygiene Index = Debris Index + Calculus Index 
Good / Fair / Poor 
Gingival index: (Loe and Silness-1963) 
   
16    =    
   
12    = 
   
24    = 
   
44    = 
   
32    = 
   
36   = 
Gingival Index(GI) =   =   
                                     24           
Mild gingivitis/Moderate gingivitis/ Severe gingivitis 
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Probing depth: 
 
palatal                           palatal                                                        palatal 
17 16 15 14 13 12 11 21 22 23 24 25 26 27 
Buccal                                                     labial                                              buccal 
Lingual                  lingual                                          lingual 
47 46 45 44 43 42 41 31 32 33 34 35 36 37 
Buccal                                                       labial             buccal 
 
CAL: 
palatal                                              palatal                                                   palatal 
17 16 15 14 13 12 11 21 22 23 24 25 26 27 
Buccal                   labial                                                 buccal 
Lingual               lingual                                              lingual 
47 46 45 44 43 42 41 31 32 33 34 35 36 37 
Buccal                                               labial                               buccal 
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Biomarker evaluation: 
Serum ALP: 
Salivary ALP: 
Investigations: 
Radiograph: 
Others: 
Diagnosis: 
Treatment: 
Date Treatment done Appointment 
date  
Staff signature 
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Clinical Parameters (post-operative) 
Indices: 
OHI-S Index: (Greene & Vermillion-1964) 
Debris        
Tooth  16 11 26 36 31 46 
Calculus       
Debris Index =          / 6 =  
Calculus Index =          / 6 =  
Oral Hygiene Index = Debris Index + Calculus Index 
Good / Fair / Poor 
Gingival index: (Loe and Silness-1963) 
   
16    =    
   
12    = 
   
24    = 
   
44    = 
   
32    = 
   
36   = 
Gingival Index(GI) =   =   
                                     24           
Mild gingivitis/Moderate gingivitis/ Severe gingivitis 
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Probing depth: 
palatal                         palatal                                                    palatal 
17 16 15 14 13 12 11 21 22 23 24 25 26 27 
Buccal                           labial                          buccal 
Lingual                                                     lingual                                                 lingual 
47 46 45 44 43 42 41 31 32 33 34 35 36 37 
Buccal                                                      labial                buccal 
CAL: 
palatal                           palatal                                                    palatal 
17 16 15 14 13 12 11 21 22 23 24 25 26 27 
Buccal                                                        labial          buccal 
Lingual                                                   lingual                                                  lingual 
47 46 45 44 43 42 41 31 32 33 34 35 36 37 
Buccal                                                     labial                                                     buccal 
Biomarker evaluation: 
Serum ALP: 
Salivary ALP: 
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PARTICIPANT INFORMED CONSENT FORM (PICF) 
(English) 
Protocol / Study number: ______________________ 
Participant identification number for this trial: _______________________ 
 The contents of the information sheet dated that was provided have been read 
carefully by me / explained in detail to me, in a language that I comprehend, and I 
have fully understood the contents.  I confirm that I have had the opportunity to ask 
questions. 
 The nature and purpose of the study and its potential risks / benefits and 
expected duration of the study, and other relevant details of the study have been 
explained to me in detail.  I understand that my participation is voluntary and that I 
am free to withdraw at any time, without giving any reason, without my medical care 
or legal right being affected. 
 I understand that the information collected about me from my participation in 
this research and sections of any of my medical notes may be looked at by 
responsible individuals from APDCH.  I give permission for these individuals to have 
access to my records. 
I agree to take part in the above study. 
 
 
 
 
 
---------------------------------------------    --------------------------------- 
(Signatures / Left Thumb Impression)  Signatures of the Principal Investigator 
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ஆ஭ாய்ச்சியில் பங்கேற்பதற்கு இணக்ேம் 
தேதி: 
த ோயோளியின் பெயர்   :   
வயது / ெோலினம்   :   
புறத ோயோளி எண் : 
அறுவவ சிகிச்வை மருத்துவ நிபுணரின் பெயர் : 
சிகிச்வையின் பெயர் :_____________________ 
அளிக்கப்ெடும் மயக்க மருந்தின் வவக : 
  
எனது ேற்தெோவேய வோய் லம் குறித்தும், அேற்கு உரிய சிகிச்வை முவறகவளயும், 
மோற்று சிகிச்வை முவறகவளயும் மற்றும் சிகிச்வை தமற்பகோள்ளோவிடில் ஏற்ெடும் 
பின்விவளவுகவளயும் ெல் மருத்துவர் முழுவமயோக என்னிடம் கூறினோர். அேற்கோன 
எனது ைந்தேகங்கவளயும் ெல்மருத்துவரிடம் தகட்டு பேளிவுெடுத்தி பகோண்தடன். 
தமலும் சிகிச்வை முவற, என் சிகிச்வையின் தெோது தேவவப்ெடும் மயக்கமருந்துகள் 
மற்றும் பிறமருந்துகள் பைலுத்ே ைம்மதிக்கின்தறன்.  ோன் மனப்பூர்வமோக எனது சிகிச்வை 
முவற மற்றும் அேனோல் வரும் பின்விவளவுகவளயும் ஏற்றுக்பகோள்கிதறன் மற்றும் 
மருத்துவர் கூறும் அறிவுவரகவளயும் கவடபிடிப்தென். 
க஫கய ச ால்யப்பட்டு இருக்கும் ஆ஭ாய்ச்சி ஆய்வில் பங்கேற்பதற்கு 
மனப்பூர்வமோன எனது  ம்஫தம். 
க஫லுள்ர தேவல்ேள் உள்ளிட்டு ஆ஭ாய்ச்சி ஆய்வானது வாய்வழி஬ாே 
விரக்ேப்பட்டிருக்கிமது ஫ற்றும் பங்கேற்பதற்கு சு஬விருப்பத்தில் இணங்குகிதறன் 
என்பது இந்த ஆவணத்தில் கேச஬ழுத்திடுவதன் அர்த்த஫ாகும். 
 
 
த ோயோளியின் வகபயோப்ெம்                அறுவவ சிகிச்வை நிபுணரின் வகபயோப்ெம் 
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